CVS Caremark prior authorization form for denosumab (Prolia) and listed biosimilars — coverage criteria
Customize your policy alerts
Sign up for all Hawaii Medical Service Association (HMSA) policy alerts
Know when Hawaii Medical Service Association (HMSA) releases new policies or updates existing guidance.
Monitor payer policy activity
This document is a CVS Caremark prior authorization form used by HMSA to collect clinical and administrative information required to authorize coverage for specific specialty osteoporosis medications (Prolia and listed biosimilars) for HMSA members. It affects prescribing clinicians and staff submitting authorization requests.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.